Health Law
Schaefer v. Herber, 789 F.3d 456 (9th Cir. 2023)
Study notes for Schaefer v. Herber: professor notes, cold call prep, exam angles, and memory aids.
Failure to disclose specific risks of a novel surgical technique constitutes a breach of the informed consent doctrine.
In Schaefer v. Herber, the court emphasized the critical importance of informed consent in healthcare, particularly when a physician uses novel techniques. The failure to disclose specific risks associated with a new surgical method can undermine the patient's autonomy and right to make informed decisions about their medical care. This case serves as a cautionary tale for physicians about the importance of transparency and comprehensive communication regarding the potential risks and benefits of treatment options, highlighting that standard procedural information may not suffice when the method involves novel risks.
Professors will likely point out how this case reinforces the legal standard of informed consent and the need for healthcare providers to ensure patients are fully informed. It also raises important questions about what constitutes material information in the context of clinical decision-making, thereby influencing standard practices in healthcare communications moving forward.
NOVA: Novel risks, Oversight, Value of information, Autonomy.
| Case | Distinction |
|---|---|
| Canterbury v. Spence | In Canterbury, the patient was not informed of any risks, while Schaefer specifically addresses the risks associated with a new technique. |
| Smith v. McGowan | Smith focused on established surgical procedures and the sufficiency of information given, whereas Schaefer deals explicitly with novel methods requiring thorough risk disclosure. |
Mandating full disclosure of risks promotes patient safety and autonomy, fostering trust in the physician-patient relationship.
Strict liability for nondisclosure may lead to defensive medicine practices, resulting in healthcare providers becoming overly cautious and potentially limiting patient access to innovative treatments.
This case may be featured in exams focusing on informed consent, with questions on the disclosure requirements for novel medical procedures and the implications for patient autonomy.